Fate Therapeutics
FATE
#9566
Rank
โ‚น10.36 B
Marketcap
โ‚น85.16
Share price
-9.01%
Change (1 day)
-8.55%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2026 (TTM): -โ‚น96.26

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น97.30. In 2025 the company made an earnings per share (EPS) of -โ‚น106.57 an increase over its 2024 EPS that were of -โ‚น151.98.

EPS history for Fate Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น96.26-9.67%
2025-โ‚น106.57-29.88%
2024-โ‚น151.98
2022-โ‚น269.6730.49%
2021-โ‚น206.657.21%
2020-โ‚น192.7545.45%
2019-โ‚น132.5219.17%
2018-โ‚น111.2017.65%
2017-โ‚น94.52-3.77%
2016-โ‚น98.23-12.4%
2015-โ‚น112.13-3.97%
2014-โ‚น116.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Becton Dickinson
BDX
โ‚น333.61-442.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น243.72 150.48%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-โ‚น121.40 24.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น645.91-763.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-โ‚น387.36 298.10%๐Ÿ‡บ๐Ÿ‡ธ USA